Official journal of the International Behavioral Neuroscience Society
Guide for Authors
Manuscripts Submission
Manuscripts may be submitted either to Randall Sakai or to Jaap Koolhaas. Authors should provide a list of the names and addresses of four referees who should not be directly associated with the research
in the submitted manuscript. On-Line Submission: For online submission upload one copy of the full paper including
graphics and all figures as graphics file separately at the online submission site, accessed via http://ees.elsevier.com/phb
The system automatically converts source files to a single Adobe Acrobat PDF version of the article, which is used in the peer-review
process. Please note that even though manuscript source files are converted to PDF at submission for the review process, these source
files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests
for revision, takes place by e-mail and via the Author's homepage, removing the need for a hard-copy paper trail.
As part of the
submission process your paper may be screened for English language usage and conformity to the guide for authors before it reaches the
review stage. This is to ensure the journal's high standards are maintained and the review process is kept to a minimum. Passing this
check is not a guarantee that your submission will subsequently proceed to the peer review process, which is a decision to be made at
the sole discretion of the journal editor.
Once a paper has been accepted by the Editor and received by Elsevier, authors can
track its progress through the system to publication, via the online author tracking system. To do this, go to http://authors.elsevier.com
ETHICS The covering letter accompanying the manuscript must include a statement that the experimental protocol was approved
by an Institutional Review Committee for the use of Human or Animal Subjects or that procedures are in compliance with at least the Declaration
of Helsinki for human subjects, or the National Institutes of Health Guide for Care and Use of Laboratory Animals (Publication No. 85-23,
revised 1985), the UK Animals Scientific Procedures Act 1986 or the European Communities Council Directive of 24 November 1986 (86/609/EEC). This statement is required both in the cover letter as well as in the Methods section of the manuscript. Manuscripts will be returned
if there is sufficient evidence that these accepted procedures and good ethical standards have not been followed.
Submission of
an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published
lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all Authors
and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published
elsewhere in the same form, in English or in any other language, without the written consent of the Publisher.
COPYRIGHT Upon acceptance of an article, Authors will be asked to sign a "Journal Publishing Agreement" (for more information on this and
copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination
of information. An e-mail or letter will be sent to the corresponding Author confirming receipt of the manuscript, together with a "Journal
Publishing Agreement" form or a link to the online version of this agreement.
If excerpts from other copyrighted works are included,
the Author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has pre-printed
forms for use by Authors in these cases: contact Elsevier's Rights Department, Oxford, UK: phone (+44) 1865 843830, fax (+44) 1865 853333,
e-mail permissions@elsevier.com. Requests may also be completed on-line via the Elsevier homepage ( http://www.elsevier.com/locate/permissions).
STYLE OF MANUSCRIPT
General Form 1. Each manuscript should be submitted and should be typewritten, double
spaced with wide margins; computer generated illustrations must be of the same quality as professional line drawings or they will not
be accepted.
2. The title page should contain: title of paper; author(s); laboratory or institution of origin with city, state, zip
code, and country; complete address for mailing proofs, including telephone and FAX numbers, and E-mail address, if available; a running
head not to exceed 40 characters including spaces between words.
3. References, footnotes, and legends for illustrations should be
typed on separate sheets, double spaced.
4. Illustrations should be identified on the reverse with figure number and author(s) name;
when necessary the top of copy should be clearly marked
5. Each table should be typed on a separate sheet and double spaced. 6.
All dimensions and measurements must be specified in the metric system.
Standard nomenclature, abbreviations and symbols, as specified
by Royal Society Conference of Editors. Metrication in Scientific Journals, Am. Scient. 56:159-164; 1968, should be used throughout. 7.
Italics should not be used for the purpose of emphasis.
Title The title should not be longer than 85 characters, including
spaces between words. Length of Paper
The Editors insist upon clear, concise statement of facts and conclusions. Fragmentation
of material into numerous short reports is discouraged. Abstract
Each paper submitted must be accompanied by an abstract
that does not exceed 250 words and must be suitable for use by abstracting journals. Abstracts should be prepared as follows:
KOSHIMIZU,
K., H. OHIGASHI AND M. A. HUFFMAN. Use of Vernonia amygdalina by wild chimpanzees: Possible roles of its bitter and related constituents.
PHYSIOL BEHAV 56(6) 000-000, 1994.—Bitter principles and related constituents have been isolated from . . .
A list of from
3-12 (or more) words or short phrases suitable for indexing terms should be typed at the bottom of the abstract page accompanying the
manuscript. These terms will be printed with the paper at the end of the abstract.
Drugs
Proprietary (trademarked) names
should be capitalized. The chemical name should precede the trade, popular name, or abbreviation of a drug the first time it occurs. Footnotes Title page footnotes should be numbered consecutively. If senior author is not to receive reprint requests, a footnote
should be given to designate to whom requests should be sent. Text footnotes should not be used; the material should be incorporated
into the text. Table footnotes: see Tables(b). References
Literature cited should be prepared according to the
Numbered style of the Council of Biology Editors. References should be cited by number, in brackets, within the text (only one reference
to a number) and listed in order of citation (double spaced) on a separate sheet at the end of the manuscript. Do not recite names
of authors within the text. Journal citations in the reference list should contain the following: (a) surnames and initials
of all authors (surname precedes initials); (b) title of article; (c) journal title abbreviation as listed in the List of
Journals Indexed in Index Medicus; (d) year, volume and inclusive pages. Example:
1. Nolte, D. L.; Mason, J. R.; Lewis,
S. L. Tolerance of bitter compounds by an herbivore, Cavia porcellus. J. Chem. Ecol. 1994, 20:303-308.
Book references should
be in the following order: author, title, city of publication, publisher, year, and pages. Examples:
1. Donegan, N. H.; Thompson,
R. F. The search for the engram. In: Martinez, J. L.; Kesner, R. P., eds. Learning and memory: A biological view. 6th ed. New York: Academic
Press; 1991:p3-58; vol. 7.
2. Myers, R. D. Handbook of drug and chemical stimulation of the brain. New York: Van Nostrand Reinhold
Company; 1974, p10-25.
Language Services Authors who require information about language editing and copyediting services
pre- and post-submission please visit http://www.elsevier.com/locate/languagepolishing or contact authorsupport@elsevier.com
for more information. Please note Elsevier neither endorses nor takes responsibility for any products, goods or services offered by outside
vendors through our services or in any advertising. For more information please refer to our terms and Conditions http://www.elsevier.com/termsandconditions
Illustrations
(a) Prepare for use in a single column width whenever possible.
(b) All drawings for reduction to a
given size should be drawn and lettered to the same scale.
(c) All illustrations should be referred to as figures and numbered in
Arabic numerals.
(d) Lettering should be done in India ink or other suitable material and must be proportionate to the size of the
illustrations if it is to be legible after reduction. Lettering should be sized so that its smallest elements (subscripts or superscripts)
will be readable when reduced.
(e) When possible all lettering should be within the framework of the illustration; likewise the key
to symbols should be on the face of the chart. The following standard symbols should be used: (open circle) (closed circle) (open triangle)
(closed triangle) (open box) (closed box) +.
(f) Actual magnification of all photomicrographs should be given. Dimension scale should
be indicated.
(g) Sharply contrasting unmounted photographs of figures on glossy paper or high quality laser prints are required.
(h) Illustrations should be submitted in black and white unless color reproduction is requested. Color prints should be submitted in
actual size and authors will be responsible for the additional costs.
Tables
(a) Each table should have a brief heading;
explanatory matter should be in footnotes, not as part of the title.
(b) Table footnotes should be indicated in the body of the table
in order of their appearance with the following symbols: * # **, etc.
(c) Tables must not duplicate material in text or illustrations.
(d) Vertical rules should be omitted.
(e) Short or abbreviated column heads should be used.
(f) Statistical measures of variation,
SD, SE, etc., should be identified.
(g) Analysis of Variance tables should not be submitted but significant F's should be incorporated
where appropriate within the text. The appropriate form for reporting F value is F(11, 20) = 3.05, p 0.01.
Formulas and Equations Structural chemical formulas, process flow-diagrams, and complicated mathematical expressions should be kept to a minimum. Usually
chemical formulas and flow-diagrams should be drawn in India ink for reproduction as line cuts.
All subscripts, superscripts, Greek letters,
and unusual characters must be clearly identified.
Anesthesia In describing surgical procedures on animals, the type
and dosage of the anesthetic agent should be specified. Curarizing agents are not anesthetics; if these were used, evidence must be provided
that anesthesia of suitable grade and duration was employed.
Preparation of supplementary data Elsevier now accepts electronic
supplementary material (e-components) to support and enhance your scientific research. Supplementary files offer the Author additional
possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips
and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products,
including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable,
please ensure that data is provided in one of our recommended file formats. Authors should submit the material in electronic format together
with the article and supply a concise and descriptive caption for each file. For more detailed instructions please visit our artwork
instruction pages at http://www.elsevier.com/artworkinstructions.
PROOFS One set of page proofs in PDF
format will be sent by e-mail to the corresponding Author (if we do not have an e-mail address then paper proofs will be sent by post).
Elsevier now sends PDF proofs which can be annotated; for this you will need to download Adobe Reader version 7 available free from
http://www.adobe.com/products/acrobat/readstep2.html. Instructions on how to annotate PDF files will accompany the proofs.
The exact system requirements are given at the Adobe site: http://www.adobe.com/products/acrobat/acrrsystemreqs.html#70win
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query Form) and return
to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, this is not possible, then mark the corrections
and any other comments (including replies to the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail
or send by post.
Please use this proof only for checking the typesetting, editing completeness and correctness of the text, tables
and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from
the Editor. We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure
that all of your corrections are sent back to us in one communication: please check carefully before replying, as inclusion of any subsequent
corrections cannot be guaranteed. Proofreading is solely your responsibility. Return corrections within 2 days of receipt of the proofs.
Note that Elsevier may proceed with the publication of your article if no response is received.
OFFPRINTS The corresponding
author, at no cost, will be provided with a PDF file of the article via e-mail or, alternatively, 25 free paper offprints. The PDF file
is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining
the terms and conditions of use.
Additional paper offprints can be ordered by the authors. An order form with prices will be sent
to the corresponding author.
AUTHOR ENQUIRIES For enquiries relating to the submission of articles please visit this
journal's homepage at http://www.elsevier.com/locate/physbeh. You can track accepted articles at http://www.elsevier.com/trackarticle
and set up e-mail alerts to inform you of when an article's status has changed, as well as copyright information, frequently asked questions
and more.
Contact details for questions arising after acceptance of an article, especially those relating to proofs, are provided
after registration of an article for publication.
SPECIAL SUBJECT REPOSITORIES As a service to our authors, Elsevier
will deposit to PubMed Central (PMC) author manuscripts on behalf of Elsevier authors reporting NIH funded research. This service is
a continuation of Elsevier's 2005 agreement with the NIH when the NIH introduced their voluntary 'Public Access Policy.'
The service
will help authors comply with the National Institutes of Health (NIH) revised ''Public Access Policy,'' effective April 7, 2008. The
NIH's revised policy requires that NIH-funded authors submit to PubMed Central (PMC), or have submitted on their behalf, their peer-reviewed
author manuscripts, to appear on PMC no later than 12 months after final publication.
Elsevier will send to PMC the final peer-reviewed
manuscript, which was accepted for publication and sent to Elsevier's production department, and that reflects any author-agreed changes
made in response to peer-review comments. Elsevier will authorize the author manuscript's public access posting 12 months after final
publication. Following the deposit by Elsevier, authors will receive further communications from Elsevier and NIH with respect to the
submission.
Authors are also welcome to post their accepted author manuscript on their personal or institutional web site. Please
note that consistent with Elsevier's author agreement, authors should not post manuscripts directly to PMC or other third party sites.
Individual modifications to this general policy may apply to some Elsevier journals and society publishing partners.
As a leading
publisher of scientific, technical and medical (STM) journals, Elsevier has led the industry in developing tools, programs and partnerships
that provide greater access to, and understanding of, the vast global body of STM information. This service is an example of Elsevier
willingness to work cooperatively to meet the needs of all participants in the STM publishing community.
DISCLAIMER Whilst
every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appears
in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole
responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors and their respective
employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any inaccurate or misleading
data, opinion or statement.
